Antares Pharma Stock News

Thousands of London's underwriters took their stamps and fountain pens home last week, which they use to sign insurance contracts, but they won't need them. Working at home due to the coronavirus loc

Antares Pharma Inc (NASDAQ:ATRS) was the target of a significant drop in short interest during the month of March. As of March 13th, there was short interest totalling 4,735,600 shares, a drop of 24.2

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Antares Pharma (NASDAQ:ATRS) was upgraded by BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued on Thursday, BidAskClub reports. Several other brokerages also

Bank of Montreal Can increased its position in Antares Pharma Inc (NASDAQ:ATRS) by 43.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 20,426 sha

Advisor Group Inc. increased its holdings in Antares Pharma Inc (NASDAQ:ATRS) by 11.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commi

Company pressing ahead despite COVID-19 pandemic.

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) Arcutis Biotherapeutics...

Panagora Asset Management Inc. purchased a new stake in shares of Antares Pharma Inc (NASDAQ:ATRS) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund purc

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) Arcutis Biotherapeutics...

On Monday morning, 720 companies hit new 52-week lows. Noteworthy Mentions: The largest company by market cap to set a new 52-week low was Alphabet (NASDAQ: GOOGL)...

Mercer Global Advisors Inc. ADV increased its position in Antares Pharma Inc (NASDAQ:ATRS) by 22.5% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional inves

(Bloomberg) -- Just when investors thought central banks were beginning to calm a global bond rout, the epicenter of chaos shifted to Australia as its market went into meltdown on March 19. The trigge

Q4 2019 Antares Pharma Inc Earnings Call